Organogenesis Holdings Stock Options Expiring on 21st of February
| ORGO Stock | USD 3.53 0.03 0.86% |
Organogenesis Holdings' latest option contracts expiring on February 21st 2025 are carrying combined implied volatility of 2.7 with a put-to-call open interest ratio of 1.27 over 6 outstanding agreements suggesting investors are buying more puts than calls on contracts expiring on February 21st 2025.
Open Interest Against February 21st 2025 Option Contracts
2025-02-21
The chart above shows Organogenesis Holdings' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Organogenesis Holdings' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Organogenesis Holdings' option, there is no secondary market available for investors to trade.
Please note that buying 'in-the-money' options on Organogenesis Holdings lessens the impact of time decay, as they carry both intrinsic and time value. So, even if Organogenesis Holdings' value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money Organogenesis Holdings contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if Organogenesis Stock moves the wrong way.
Organogenesis Holdings In The Money Call Balance
When Organogenesis Holdings' strike price is surpassing the current stock price, the option contract against Organogenesis Holdings stock is said to be in the money. When it comes to buying Organogenesis Holdings' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Organogenesis Holdings are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Organogenesis Current Options Market Mood
Organogenesis Holdings' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Organogenesis Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Unfortunately, most Organogenesis Holdings' options investors are not very successful. Organogenesis Holdings' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Organogenesis contract
Base on the Rule 16, the options market is currently suggesting that Organogenesis Holdings will have an average daily up or down price movement of about 0.17% per day over the life of the 2025-02-21 option contract. With Organogenesis Holdings trading at USD 3.53, that is roughly USD 0.005957. If you think that the market is fully incorporating Organogenesis Holdings' daily price movement you should consider buying Organogenesis Holdings options at the current volatility level of 2.7%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Organogenesis |
Organogenesis Holdings Option Chain
When Organogenesis Holdings' strike price is surpassing the current stock price, the option contract against Organogenesis Holdings stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Organogenesis Holdings' option chain is a display of a range of information that helps investors for ways to trade options on Organogenesis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Organogenesis. It also shows strike prices and maturity days for a Organogenesis Holdings against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Strike Price | Current Spread | Last Price | |||
Call | ORGO250221C00002500 | 10 | 2.5 | 0.0 - 1.45 | 1.5 | In |
Call | ORGO250221C00005000 | 1 | 5.0 | 0.0 - 0.4 | 0.05 | Out |
Call | ORGO250221C00007500 | 0 | 7.5 | 0.0 - 1.9 | 1.9 | |
Put | ORGO250221P00002500 | 0 | 2.5 | 0.0 - 1.95 | 1.95 | |
Put | ORGO250221P00005000 | 10 | 5.0 | 0.0 - 1.9 | 2.7 | In |
Put | ORGO250221P00007500 | 4 | 7.5 | 3.6 - 4.4 | 4.6 | In |
Organogenesis Holdings Selling And Marketing Expenses Over Time
Selling And Marketing Expenses |
| Timeline |
Organogenesis Holdings Market Cap Over Time
Market Cap |
| Timeline |
Organogenesis Total Stockholder Equity
Total Stockholder Equity |
|
Organogenesis Holdings Corporate Management
| BA Esq | VP Counsel | Profile | |
| Patrick Bilbo | Chief Officer | Profile | |
| Thomas Pearl | Vice Resources | Profile | |
| Zorina Pitkin | VP Systems | Profile | |
| Brian Grow | Chief Officer | Profile | |
| Kurt Matheson | VP Marketing | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Organogenesis Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.05) | Revenue Per Share | Quarterly Revenue Growth 0.061 | Return On Assets |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.